Literature DB >> 7658028

Determination of transforming growth factor beta 2 in human blood samples by ELISA.

C H Szymkowiak1, I Mons, W L Gross, J Kekow.   

Abstract

Transforming growth factors beta (TGF beta s) show pleotrophic functions in vitro and in vivo. Biological effects depend on the cell type, the TGF beta isoform, and the availability of active TGF beta. Bioassays for TGF beta have not proven to be reliable tools in the measurement of TGF beta in human blood samples. Previously described sandwich ELISAs for measuring TGF beta are limited to single TGF beta isoforms and have not been evaluated for use in human sera or plasma. We describe a simple procedure to quantitate not only TGF beta 1 but also TGF beta 2 in human blood samples using commercially available antibodies. The sensitivity of the TGF beta 2 ELISA was 11 pg/ml. There was no crossreactivity between the TGF beta 1 and TGF beta 3 isoforms. High concentrations of TGF beta 1 and TGF beta 3 in spiked samples did not interfere with TGF beta 2 determination. TGF beta 2 recovery was highest in EDTA plasma (> 88%), and the intra- and interassay variance was 6% and 8.5% respectively. Applying the ELISA to human plasma specimens a significant percentage of TGF beta 2 (3.7 +/- 0.8 ng/ml) was found (about 50% of the TGF beta 1 content).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658028     DOI: 10.1016/0022-1759(95)00098-u

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations.

Authors:  Katja Heinemeier; Henning Langberg; Michael Kjaer
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

2.  Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum.

Authors:  Ger van Zandbergen; Annalena Bollinger; Alexander Wenzel; Shaden Kamhawi; Reinhard Voll; Matthias Klinger; Antje Müller; Christoph Hölscher; Martin Herrmann; David Sacks; Werner Solbach; Tamás Laskay
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

Authors:  Thomas Schneider; Michael Sailer; Siegfried Ansorge; Raimund Firsching; Dirk Reinhold
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

4.  Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Authors:  Juergen Luhm; Ulrich Langenkamp; Jenny Hensel; Christoph Frohn; Joerg M Brand; Holger Hennig; Lothar Rink; Petra Koritke; Nadine Wittkopf; David L Williams; Antje Mueller
Journal:  BMC Immunol       Date:  2006-03-22       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.